Bone and In-111 octreotide imaging in oncogenic osteomalacia: A case report

Clinical Nuclear Medicine

Volumn 27, Issue 8, 2002, Pages 582-583

  Garcia, Carlos A ^a   Spencer, Richard P ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Bone Scan; In 111 Octreotide; Oncogenic Osteomalacia

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PENTETREOTIDE IN 111;

ADULT; AGING; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; DIAGNOSTIC IMAGING; HUMAN; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; LEUKOCYTE COUNT; MALE; MALIGNANT TRANSFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; OSTEOMALACIA; OSTEOPOROSIS;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HUMERUS; HYPERPARATHYROIDISM; MALE; MESENCHYMOMA; MIDDLE AGED; OCTREOTIDE; OSTEOMALACIA; RADIOPHARMACEUTICALS;

EID: 0036705952     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200208000-00007     Document Type: Article

References (6)

1. Uchida H, Yokoyanna S, Kashiima K, et al: Oncogenic vitamin D resistant hypophosphatemic osteomalacia (benign ossifying mesenchymal tumor of bone): case report. Jpn J Clin Oncol 21:218, 1991.
2. Leicht E, Kramann B, Seitz G, et al: Oncogenic osteomalacia: imaging studies. Bildgebung 60:13, 1993.
3. Shimada T, Mizutani S, Muto T, et al: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:5945, 1998.
4. Shimada A, Mizutani S, Muto T, et al: Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500, 2001.
5. White KE, Jonsson KB, Carn G, et al: The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497, 2001.
6. Sahin M, Basoglu T, Albayrak S, et al: Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia. Clin Nucl Med 26:62, 2001.